Cargando…

Repurposing antimalarials and other drugs for COVID-19

Detalles Bibliográficos
Autores principales:	Schlagenhauf, Patricia, Grobusch, Martin P., Maier, Julian D., Gautret, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194516/ https://www.ncbi.nlm.nih.gov/pubmed/32247925 http://dx.doi.org/10.1016/j.tmaid.2020.101658

Ejemplares similares

Where do Eritrean migrants get infected with malaria? The importance of considering the migration route
por: Gautret, Philippe, et al.
Publicado: (2019)

Repurposing Antimalarials to Tackle the COVID-19 Pandemic
por: Krishna, Sanjeev, et al.
Publicado: (2021)

Variants, vaccines and vaccination passports: Challenges and chances for travel medicine in 2021
por: Schlagenhauf, Patricia, et al.
Publicado: (2021)

Cinnamic Acid Conjugates in the Rescuing and Repurposing of Classical Antimalarial Drugs
por: Silva, Ana Teresa, et al.
Publicado: (2019)

COVID-19 impact on EuroTravNet infectious diseases sentinel surveillance in Europe
por: Grobusch, Martin P., et al.
Publicado: (2023)

Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
por: Bhise, Neha, et al.
Publicado: (2023)

In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus
por: Tietcheu Galani, Borris Rosnay, et al.
Publicado: (2021)

Repurposing Antimalarials to Tackle the COVID-19 Pandemic: (Trends in Parasitology 37, 8–11; 2021)
por: Krishna, Sanjeev, et al.
Publicado: (2021)

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases
por: Mee-udorn, Pitchayathida, et al.
Publicado: (2023)

Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization
por: McAnally, Danielle, et al.
Publicado: (2018)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Buying time: Drug repurposing to treat the host in COVID‐19H
por: Martin, Jennifer H., et al.
Publicado: (2020)

Infection risks associated with the 2022 FIFA World Cup in Qatar
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2022)

Travel-related respiratory symptoms and infections in travellers (2000–22): a systematic review and meta-analysis
por: Lovey, Thibault, et al.
Publicado: (2023)

Repurposing Heparin as Antimalarial: Evaluation of Multiple Modifications Toward In Vivo Application
por: Lantero, Elena, et al.
Publicado: (2020)

Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection
por: Lane, Thomas R., et al.
Publicado: (2019)

Repurposing fluvoxamine, and other psychiatric medications, for COVID‐19 and other conditions
por: Lenze, Eric J., et al.
Publicado: (2022)

Will the antimalarial drug take over to combat COVID-19?
por: T.K, Sivabakya, et al.
Publicado: (2020)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

Perspective: repurposed drugs for COVID-19
por: Na-Bangchang, Kesara, et al.
Publicado: (2022)

Repurposing metabolic drugs for COVID-19
por: Bordon, Yvonne
Publicado: (2023)

Repurposing antimalarial artesunate for the prophylactic treatment of depression: Evidence from preclinical research
por: Huang, Shihao, et al.
Publicado: (2022)

Network analytics for drug repurposing in COVID-19
por: Siminea, Nicoleta, et al.
Publicado: (2021)

Integrated computational approach towards repurposing of antimalarial drug against SARS-CoV-2 main protease
por: Gogoi, Neelutpal, et al.
Publicado: (2022)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Artificial intelligence in COVID-19 drug repurposing
por: Zhou, Yadi, et al.
Publicado: (2020)

Transcription-based drug repurposing for COVID-19
por: Killick, Richard, et al.
Publicado: (2020)

Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

Assessment of the proarrhythmic effects of repurposed antimalarials for COVID-19 treatment using a comprehensive in vitro proarrhythmia assay (CiPA)
por: Yoon, Seung-Hyun, et al.
Publicado: (2023)

Trends in Antimalarial Drug Use in Africa
por: Flegg, Jennifer A., et al.
Publicado: (2013)

Ethics and Antimalarial Drug Resistance
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)

Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
por: Villoutreix, Bruno O., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1d45cuud9sjj46rb5bdp769al2